MARKET

VYYRF

VYYRF

Voyageur Pharmaceuticals Ltd
OTCPK
0.087
NaN%
Closed 09:30 10/28 EDT
OPEN
--
PREV CLOSE
0.087
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
1.000
52 WEEK LOW
0.0033
MARKET CAP
19.69M
P/E (TTM)
-5.5063
1D
5D
1M
3M
1Y
5Y
1D
Voyageur Pharmaceuticals Converts Debt to Equity to Preserve Cash and Advance Contrast Media Strategy
TipRanks · 10/02 21:39
Voyageur Pharmaceuticals Announces Completion of Shares for Debt Settlement
Newsfile · 10/02 20:29
Voyageur Pharmaceuticals Converts Debt to Equity to Preserve Cash
TipRanks · 09/24 22:07
Voyageur Pharmaceuticals to settle $192,300 debt with shares
Seeking Alpha · 09/24 22:02
Voyageur Pharmaceuticals Announces Proposed Issuance of Shares for Debt
Newsfile · 09/24 21:52
Voyageur advances high-purity iodine extraction with field pilot plans
TipRanks · 08/10 12:52
Voyageur Pharmaceuticals Announces the Engagement of Red Cloud Securities as Market Maker
Newsfile · 07/17 21:30
Voyageur Pharmaceuticals Launches Up to $7.5 Million Private Placement to Advance Contrast Media Projects
TipRanks · 03/25 14:20
More
About VYYRF
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine active pharmaceutical ingredients (API) and imaging contrast agents for medical radiology. It focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

Webull offers Voyageur Pharmaceuticals Ltd stock information, including OTCPK: VYYRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYYRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYYRF stock methods without spending real money on the virtual paper trading platform.